Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Disc Medicine (IRON – Research Report) and keeping the price target at $112.00. Evan Seigerman has given his Buy rating due to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback